NeoGenomics Inc (NEO)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | -92,106 | -107,736 | -153,107 | -9,993 | -2,131 |
| Revenue | US$ in thousands | 660,566 | 591,643 | 509,728 | 484,329 | 444,448 |
| Operating profit margin | -13.94% | -18.21% | -30.04% | -2.06% | -0.48% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $-92,106K ÷ $660,566K
= -13.94%
The operating profit margin of NeoGenomics Inc has shown a declining trend over the past five years. Starting at -0.48% as of December 31, 2020, the margin deteriorated to -2.06% by December 31, 2021, and further declined significantly to -30.04% by December 31, 2022. Despite some improvement in the following years, the margin remained negative, with values of -18.21% as of December 31, 2023, and -13.94% by December 31, 2024. This indicates that the company's operating expenses have been relatively high compared to its revenue, leading to lower profitability from its core operations. Management may need to address cost efficiencies and revenue generation strategies to improve the company's operating profit margin in the future.